PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy. Chuang FC, Wang CC, Chen JH, Hwang TZ, et al. PLoS One 2021;16:e0245715.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chuang FC, Wang CC, Chen JH, Hwang TZ, et al. PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy. PLoS One 2021;16:e0245715.
PMID: 33471836